Clinical Trial Update: CT-Guided Adaptive Radiation Therapy Combine With Anti-PD-1 Antibody Adjuvant Immunotherapy for Thoracic Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CT-guided adaptive radiation therapy in combination with anti-PD-1 antibody adjuvant immunotherapy for thoracic malignancies…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracic Malignancies

Drugs mentioned

• Anti-PD-1 antibody

Snippet

Sponsor: Taizhou Hospital | Conditions: Thoracic Malignancies | Phase 2 | Status: UNKNOWN